Episode 128 - Finerenone with SGLT2 inhibitors for CKD and Type 2 Diabetes

Send us a text

Welcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the simultaneous initiation of SGLT2 inhibitors and finerenone (a nonsteroidal mineralocorticoid receptor antagonist) in persons with chronic kidney disease and type 2 diabetes. Here we go!

1. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (0:00 – 9:28).

Calling keen trainees! (9:29 - 10:28)

• Trainees, med students, residents: The Rounds Table and Trial Files are looking for keen individuals to support our efforts.
• Trial Files is a free monthly newsletter on practice-changing trials, delivered straight to your inbox (https://trialfiles.substack.com/).
• Reach out to [email protected] if you are interested in getting involved. 

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods